Contact allergy to SIDAPA baseline series allergens in patients with eyelid dermatitis : An Italian multicentre study
© 2024 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd..
BACKGROUND: Eyelid dermatitis is a frequent reason of dermatological consultation. Its aetiology is not univocal, being contact dermatitis, both allergic and irritant, the most frequent. The primary sources of allergen exposure include cosmetics, metals, and topical medications, from direct, indirect, or airborne contact.
OBJECTIVES: To define the frequency of positive patch test reactions to SIDAPA baseline series allergens, to document positive allergens, and to precise the final diagnosis in patients with eyelid involvement.
METHODS: A total of 8557 consecutive patients from 12 Italian Dermatology Clinics underwent patch testing with SIDAPA baseline series in 2018 and 2019. Patients were divided into two groups: (i) with eyelid involvement with or without other involved sites (E-Group) and (ii) without eyelid involvement (NE-Group). The final diagnosis and the frequency of positive relevant patch test reactions were evaluated.
RESULTS: E-Group consisted of 688 patients (females 78.6%, mean age 45.3 years), 8.0% of 8557 consecutively patch-tested patients. The final diagnosis in E-Group was ADC in 42.4%, ICD in 34.2%, and AD in 30.5%. The highest reaction rates were elicited by nickel sulphate and methylchloroisothiazolinone/methylisothiazolinone in both E-Group and NE-Group, even if these allergens were significantly more frequently positive in NE-Group patients than in E-Group ones. Positive patch test reactions to fragrance Mix II, dimethylaminopropylamine, and sorbitan sesquiolate were significantly more frequent in E-Group patients than in NE-Group ones.
CONCLUSIONS: Eyelid dermatitis is a frequent dermatological complaint. Allergic contact dermatitis is the most frequent diagnosis commonly caused by nickel sulphate, isothiazolinones, and fragrances. The surfactants dimethylaminopropylamine and sorbitan sesquioleate are emerging causes of eyelid allergic contact dermatitis.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:90 |
|---|---|
| Enthalten in: |
Contact dermatitis - 90(2024), 5 vom: 01. Apr., Seite 479-485 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Stingeni, Luca [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
4FLT4T3WUN |
|---|
| Anmerkungen: |
Date Completed 08.04.2024 Date Revised 08.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/cod.14507 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367585499 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367585499 | ||
| 003 | DE-627 | ||
| 005 | 20240408232255.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240125s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/cod.14507 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1369.xml |
| 035 | |a (DE-627)NLM367585499 | ||
| 035 | |a (NLM)38268123 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Stingeni, Luca |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Contact allergy to SIDAPA baseline series allergens in patients with eyelid dermatitis |b An Italian multicentre study |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.04.2024 | ||
| 500 | |a Date Revised 08.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. | ||
| 520 | |a BACKGROUND: Eyelid dermatitis is a frequent reason of dermatological consultation. Its aetiology is not univocal, being contact dermatitis, both allergic and irritant, the most frequent. The primary sources of allergen exposure include cosmetics, metals, and topical medications, from direct, indirect, or airborne contact | ||
| 520 | |a OBJECTIVES: To define the frequency of positive patch test reactions to SIDAPA baseline series allergens, to document positive allergens, and to precise the final diagnosis in patients with eyelid involvement | ||
| 520 | |a METHODS: A total of 8557 consecutive patients from 12 Italian Dermatology Clinics underwent patch testing with SIDAPA baseline series in 2018 and 2019. Patients were divided into two groups: (i) with eyelid involvement with or without other involved sites (E-Group) and (ii) without eyelid involvement (NE-Group). The final diagnosis and the frequency of positive relevant patch test reactions were evaluated | ||
| 520 | |a RESULTS: E-Group consisted of 688 patients (females 78.6%, mean age 45.3 years), 8.0% of 8557 consecutively patch-tested patients. The final diagnosis in E-Group was ADC in 42.4%, ICD in 34.2%, and AD in 30.5%. The highest reaction rates were elicited by nickel sulphate and methylchloroisothiazolinone/methylisothiazolinone in both E-Group and NE-Group, even if these allergens were significantly more frequently positive in NE-Group patients than in E-Group ones. Positive patch test reactions to fragrance Mix II, dimethylaminopropylamine, and sorbitan sesquiolate were significantly more frequent in E-Group patients than in NE-Group ones | ||
| 520 | |a CONCLUSIONS: Eyelid dermatitis is a frequent dermatological complaint. Allergic contact dermatitis is the most frequent diagnosis commonly caused by nickel sulphate, isothiazolinones, and fragrances. The surfactants dimethylaminopropylamine and sorbitan sesquioleate are emerging causes of eyelid allergic contact dermatitis | ||
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a allergic contact dermatitis | |
| 650 | 4 | |a contact allergens | |
| 650 | 4 | |a eyelid | |
| 650 | 4 | |a patch test | |
| 650 | 7 | |a Allergens |2 NLM | |
| 650 | 7 | |a nickel sulfate |2 NLM | |
| 650 | 7 | |a 4FLT4T3WUN |2 NLM | |
| 650 | 7 | |a Nickel |2 NLM | |
| 650 | 7 | |a 7OV03QG267 |2 NLM | |
| 700 | 1 | |a Foti, Caterina |e verfasserin |4 aut | |
| 700 | 1 | |a Guarneri, Fabrizio |e verfasserin |4 aut | |
| 700 | 1 | |a Corazza, Monica |e verfasserin |4 aut | |
| 700 | 1 | |a Cristaudo, Antonio |e verfasserin |4 aut | |
| 700 | 1 | |a Ferrucci, Silvia Mariel |e verfasserin |4 aut | |
| 700 | 1 | |a Gallo, Rosella |e verfasserin |4 aut | |
| 700 | 1 | |a Martina, Emanuela |e verfasserin |4 aut | |
| 700 | 1 | |a Musumeci, Maria Letizia |e verfasserin |4 aut | |
| 700 | 1 | |a Napolitano, Maddalena |e verfasserin |4 aut | |
| 700 | 1 | |a Nettis, Eustachio |e verfasserin |4 aut | |
| 700 | 1 | |a Patruno, Cataldo |e verfasserin |4 aut | |
| 700 | 1 | |a Pigatto, Paolo Daniele |e verfasserin |4 aut | |
| 700 | 1 | |a Piras, Viviana |e verfasserin |4 aut | |
| 700 | 1 | |a Schena, Donatella |e verfasserin |4 aut | |
| 700 | 1 | |a Casciola, Gabriele |e verfasserin |4 aut | |
| 700 | 1 | |a Antonelli, Elettra |e verfasserin |4 aut | |
| 700 | 1 | |a Hansel, Katharina |e verfasserin |4 aut | |
| 700 | 0 | |a SIDAPA Study Group |e verfasserin |4 aut | |
| 700 | 1 | |a Bianchi, Leonardo |e investigator |4 oth | |
| 700 | 1 | |a Borghi, Alessandro |e investigator |4 oth | |
| 700 | 1 | |a Campanati, Anna |e investigator |4 oth | |
| 700 | 1 | |a Mariano, Maria |e investigator |4 oth | |
| 700 | 1 | |a Pascucci, Enrico |e investigator |4 oth | |
| 700 | 1 | |a Pugliese, Francesco |e investigator |4 oth | |
| 700 | 1 | |a Romita, Paolo |e investigator |4 oth | |
| 700 | 1 | |a Tramontana, Marta |e investigator |4 oth | |
| 700 | 1 | |a Trave, Ilaria |e investigator |4 oth | |
| 700 | 1 | |a Zussino, Martina |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Contact dermatitis |d 1981 |g 90(2024), 5 vom: 01. Apr., Seite 479-485 |w (DE-627)NLM000341193 |x 1600-0536 |7 nnns |
| 773 | 1 | 8 | |g volume:90 |g year:2024 |g number:5 |g day:01 |g month:04 |g pages:479-485 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/cod.14507 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 90 |j 2024 |e 5 |b 01 |c 04 |h 479-485 | ||